Date of event
Continuing Education Credits
Public Policy Committee
Donna Kimbark, PhD
The Peer Reviewed Cancer Research Program webinar will present funding opportunities for liver cancer through the Department of Defense. This webinar will cover topics including how to apply, what opportunities are available, as well as hints and tips on how to succeed in applying to the Department of Defense Congressionally Directed Medical Research Programs.
Donna M. Kimbark, PhD
Donna M. Kimbark currently serves as the Program Manager at the Congressionally Directed Medical Research Programs, U.S. Army Medical Research and Development Command.
In 1996, Dr. Kimbark received her PhD in Molecular Pharmacology and Cancer Therapeutics from the State University of New York at Buffalo, Roswell Park Cancer Institute. Following postdoctoral training at Johns Hopkins Medical Institute, Dr. Kimbark worked in the biotechnology sector before joining the Congressionally Directed Medical Research Programs (CDMRP) in 2002 as Science Officer for the Breast Cancer Research Program. During her time as a Science Officer, Dr. Kimbark also served on the Institution Based Research Program group and served as Chair of the Consumer Working Group. While working in grants management, she received her certificate in Epidemiology and Biostatistics from Drexel University. In 2008, Dr. Kimbark was promoted to Program Manager for the Peer Reviewed Cancer Research Program. Throughout her years at CDMRP, Dr. Kimbark has led multiple research funding programs including Autism, Multiple Sclerosis, Kidney Cancer, and Bone Marrow Failure Research Programs. Currently, she leads the program teams for the Peer Reviewed Cancer Research Program and the Melanoma Research Program. In addition to her programmatic duties, Dr. Kimbark also leads the Funding Opportunities Announcement team, where she coordinates the creation and revisions solicitation templates for grants. For her efforts, she has been awarded the Commander’s Award for Civilian Service. Her areas of expertise include cancer therapeutics, pharmacology, proteomics, and scientific research administration.